What is the translation of " HYPERAEMIA " in Croatian?

• hiperemija
• hiperemiju

Examples of using Hyperaemia in English and their translations into Croatian

Conjunctival hyperaemia, dry eye.
Konjunktivalna hiperemija, suho oko.

Visual impairment, oscillopsia, binocular eye movement disorder, ocular hyperaemia.
Oštećenje vida, oscilopsija, poremećaji binokularnog kretanja očiju, očna hiperemija.

Cataract, ocular hyperaemia, vision blurred.
Katarakta, okularna hiperemija, zamagljen vid.

Glaucoma, eye movement disorderc, eye rollingc, lacrimation increased, ocular hyperaemia.
Glaukom, poremećaj kretanja očijuc, preokretanje očiju, pojačana lakrimacija, okularna hiperemija.

Conjunctival hyperaemia, ocular pruritus, growth of eyelashes.
Hiperemija konjunktive, svrbež oka, rast trepavica.

The most frequent adverse reactions reported in the paediatric population were ocular hyperaemia(16.9%) and growth of eyelashes 6.5.
Najčešće zabilježene nuspojave u pedijatrijskoj populaciji bile su okularna hiperemija(16,9%) i rast trepavica 6, 5.

Conjunctival hyperaemia Abnormal sensation in eye Ocular discomfort.
Konjuktivalna hiperemija Abnormalan osjet u oku Osjećaj neugode u oku.

The most common side effect(seen in more than 1 patient in 10) is conjunctival hyperaemia increased blood supply to the eye, leading to redness of the eye.
Najčešća nuspojava(zabilježena u više od 1 na 10 bolesnika) je konjunktivalna hiperemija povećan dotok krvi u oko što dovodi do crvenila oka.

Retinal ischaemia*, retinopathy*, abnormal sensation in eye, conjunctival haemorrhage, conjunctivitis, eye pain, eye pruritus, eye swelling, eyelid oedema, lacrimation increased, ocular hyperaemia, photophobia.
Ishemija mrežnice*, retinopatija*, neuobičajeni osjeti u oku, krvarenje iz očne spojnice, konjunktivitis, bol u oku, svrbež oka, oticanje oka, edem vjeđe, pojačano suzenje, očna hiperemija, fotofobija.

Visual disturbance Ocular hyperaemia Blurred vision Visual acuity reduced.
Metnje vida, okularna hiperemija, zamagljen vid, smanjena oštrina vida.

The most common side effects with Emadine(which may affect between 1 and 2 patients in 100) are eye pain, eye pruritus(itchy eye) and conjunctival hyperaemia increased blood flow to the eye, leading to redness.
Najčešće nuspojave lijeka Emadine(koje su uočene u 1 do 2 bolesnika na 100 bolesnika) su bolne oči, pruritus oka(svrbež oka) i konjunktivalna hiperemija povećani protok krvi u oku, što uzrokuje crvenilo.

The patient also developed mild conjunctival hyperaemia, eye inflammation and miosis which resolved with corticosteroid eye drops.
Bolesnik je razvio i blagu hiperemiju konjunktive, upalu oka i miozu koje su prošle nakon primjene kortikosteroidnih kapi za oči.

Iliac artery thrombosis, hypovolaemic shock, arterial limb thrombosis, thrombosis, flushing, pelvic venous thrombosis, thrombophlebitis, phlebitis, phlebitis superficial, orthostatic hypotension, haematoma, hyperaemia, hot flush.
Tromboza ilijačne arterije, hipovolemijski šok, arterijska tromboza udova, tromboza, crvenilo, venska zdjelična tromboza, tromboflebitis, flebitis, površinski flebitis, ortostatska hipotenzija, hematomi, hiperemija, navale vrućine.

Feed supplement"Renal Edvansed" for cats improves the function of the digestive system, reduces hyperaemia and oxidative stress, normalizes non-regenerative anemia.
Dodatak hrani"Renal Edvansed" za mačke poboljšava funkciju probavnog sistema, smanjuje hiperemiju i oksidativni stres, normalizuje ne-regenerativnu anemiju.

Conjunctival hyperaemia, growth of eyelashes, and eye pruritus were statistically significantly higher with bimatoprost than with latanoprost, however, the discontinuation rates due to adverse events were low with no statistically significant difference.
Konjunktivna hiperemija, rast trepavica i svrbež oka bili su statistički značajno viši s bimatoprostom u usporedbi s latanoprostom, međutim, stope prekida zbog nuspojava bile su niske i bez statistički značajne razlike.

The most frequently reported adverse reactions were, eye pain(4.8%), anterior chamber inflammation(3.9%), conjunctival hyperaemia(2.2%), photophobia(1.7%), corneal oedema(1.3%) and inflammation 1.3.
Najčešće prijavljene nuspojave bile su bol u oku(4,8%), upala prednje komore(3,9%), konjuktivalna hiperemija(2,2%), fotofobija(1,7%), edem rožnice(1,3%) i upala 1, 3.

Necrotizing retinitis, endophthalmitis*, glaucoma, retinal detachment*, retinal tear*, hypotony of the eye*, anterior chamber inflammation*, anterior chamber cells/ flares*, abnormal sensation in eye*, eyelids pruritus, scleral hyperaemia.
Nekrotizirajući retinitis, endoftalmitis*, glaukom, odvajanje mrežnice*, ruptura mrežnice*, hipotonija oka*, upala prednje komore*, stanice u prednjoj komori/ bljeskovi*, neuobičajen osjet u oku*, svrbež očnih kapaka, skleralna hiperemija.

Hypertension(increased blood pressure, procedural hypertension, increased diastolic blood pressure), flushing(including hot flush, hyperaemia, night sweats), hypotension including decreased blood pressure.
Hipertenzija(povišeni krvni tlak, proceduralna hipertenzija, povišeni dijastolički krvni tlak), navala crvenila(uključujući valunge, hiperemiju, noćno znojenje), hipotenzija uključujući sniženi krvni tlak.

Ocular hypertension, cataract subcapsular, vitreous haemorrhage*, visual acuity reduced*, visual impairment/ disturbance, vitreous detachment*, vitreous floaters*, vitreous opacities*, blepharitis, eye pain*, photopsia*, conjunctival oedema* conjunctival hyperaemia.
Okularna hipertenzija, subkapsularna katarakta, vitrealno krvarenje*, smanjena oštrina vida*, oštećenje/smetnje vida, odvajanje staklovine*, opaciteti u staklovini*, zamućenje staklovine*, blefaritis, bol u oku*, fotopsija*, edem konjunktive* hiperemija konjunktive.

In a clinical trial of 3 months duration(N 442) involving IZBA as monotherapy, the most common adverse reaction observed was hyperaemia of the eye(ocular or conjunctival) reported in approximately 12% of the patients.
U kliničkoj studiji u trajanju od 3 mjeseca(N=442) koja je uključila IZBU kao monoterapiju, najčešće zabilježena nuspojava bila je hiperemija oka(okularna ili konjunktivalna) prijavljena u otprilike 12% bolesnika.

Cerebrovascular accident, Deep vein thrombosis*, Haemorrhage*, Thrombophlebitis(inc superficial), Circulatory collapse(inc hypovolaemic shock), Phlebitis, Flushing*, Haematoma(inc perirenal)*, Poor peripheral circulation*, Vasculitis, Hyperaemia inc ocular.
Cerebrovaskularni događaj, duboka venska tromboza*, krvarenje*, tromboflebitis(uključujući površinski), kolaps cirkulacije(uključujući hipovolemijski šok), flebitis, crvenilo uz osjećaj vrućine*, hematomi(uključujući perirenalne)*, slaba periferna cirkulacija*, vaskulitis, hiperemija uključujući okularnu.

Signs and symptoms included chest discomfort, conjunctival injection, dyspnoea, generalised and itchy rash, hyperaemia, mild eyelid oedema, rhinorrhoea, severe respiratory distress, tachycardia, tachypnoea and urticaria.
Znakovi i simptomi uključivali su nelagodu u prsištu, injekciju konjunktive, dispneju, generaliziran osip koji svrbi, hiperemiju, blagi edem vjeđa, rinoreju, težak respiratorni distres, tahikardiju, tahipneju i urtikariju.

Conjunctival hyperaemia(mostly trace to mild and thought to be of a non-inflammatory nature) in up to 44% in the first year with the incidence of new reports decreasing to 13% at 2 years and 12% at 3 years ocular pruritus in up to 14% of patients in the first year with the incidence of new reports decreasing to 3% at 2 years and 0% at 3 years.
Konjunktivna hiperemija(većinom u tragovima do blaga i vjerojatno neupalne prirode) i do 44% u prvoj godini primjene s padom incidencije novih prijava na 13% u drugoj i 12% u trećoj godini primjene. svrbež očiju i do 14% u prvoj godini primjene s padom incidencije na 3% u drugoj i 0% u trećoj godini primjene.

The most common side effects when using Travatan(seen in more than 1 patient in 10) are ocular hyperaemia(increased blood supply to the eye, leading to eye irritation and redness) and iris hyperpigmentation darkening of the colour of the iris.
Najčešće nuspojave lijeka Travatan(mogu se javiti u više od 1 na 10 osoba) su okularna hiperemija(povišena isporuka krvi u oko, što rezultira nadraženošću i crvenilom oka) kao i hiperpigmentacija rožnice tamnjenje rožnice.

The most common side effects with Ikervis(which may affect more than 1 in 10 people) are pain and irritation in the eye; other common side effects are lacrimation(excessive tears), ocular hyperaemia(red eye), and erythema(redness) of the eyelid.
Najčešće nuspojave lijeka Ikervis(mogu se javiti u više od 1 na 10 osoba) su bol i nadraženost u oku; druge uobičajene nuspojave su lakrimacija(prekomjerne suze), okularna hiperemija(crveno oko) i eritema(crvenilo) očnog kapka.

Based on 12-month clinical data, the most commonly reported adverse reaction was conjunctival hyperaemia(mostly trace to mild and thought to be of a non-inflammatory nature) in approximately 26% of patients and led to discontinuation in 1.5% of patients.
Na temelju 12-mjesečnih kliničkih podataka, najčešće prijavljena nuspojava bila je hiperemija konjunktive(uglavnom u tragovima ili u blagom obliku te se smatralo da nije upalne prirode) u približno 26% bolesnika, a koja je kod 1,5% bolesnika dovela do prekida terapije.

In small short-term clinical trials, approximately 12.5% of paediatric patients were observed to experience adverse reactions, the majority of which were local, non-serious ocular reactions such as conjunctival hyperaemia, eye irritation, eye discharge, and lacrimation increased see also section 5.1.
U manjim kratkoročnim kliničkim ispitivanja nuspojave su zabilježene kod otprilike 12, 5% pedijatrijskih bolesnika, od kojih su većina bile lokalne, neozbiljne okularne reakcije poput konjunktivalne hiperemije, iritacije oka, iscjetka iz oka i pojačanog suzenja vidjeti također dio 5.1.

In clinical trials involving SIMBRINZA dosed twice-daily the most common adverse reactions were ocular hyperaemia and ocular allergic type reactions occurring in approximately 6-7% of patients, and dysgeusia(bitter or unusual taste in the mouth following instillation) occurring in approximately 3% of patients.
U kliničkim ispitivanjima koja su uključila SIMBRINZU primijenjenu dva puta dnevno, najučestalije nuspojave bile su okularna hiperemija i okularne reakcije alergijskog tipa, zabilježeno kod otprilike 6-7% bolesnika, i disgeuzija(gorak ili neobičan okus u ustima nakon primjene) zabilježena kod otprilike 3% bolesnika.

Corneal erosion, corneal epithelium defect, corneal epithelium disorder, punctate keratitis, keratitis, corneal staining, eye discharge, photophobia, vision blurred, visual acuity reduced, blepharospasm, ocular discomfort, eye pruritus, conjunctival follicles, conjunctival disorder, foreign body sensation in eyes, lacrimation increased, erythema of eyelid, eyelid oedema, eyelid disorder, ocular hyperaemia.
Erozija rožnice, defekt rožničnog epitela, poremećaj epitela rožnice, točkasti keratitis, keratitis, obojenje rožnice, iscjedak iz oka, fotofobija, zamućen vid, smanjena vidna oštrina, blefarospazam, neugodan osjećaj u oku, svrbež oka, konjunktivalni folikuli, poremećaj konjunktive, osjećaj stranog tijela u oku, pojačano suzenje, eritem vjeđa, edem vjeđa, poremećaj vjeđa, okularna hiperemija.

Based on a 12-week study of GANFORT single-dose administered once daily, the most commonly reported adverse reaction with GANFORT single-dose was conjunctival hyperaemia(mostly trace to mild and thought to be of a non-inflammatory nature) in approximately 21% of patients and led to discontinuation in 1.4% of patients.
Na temelju 12-mjesečnog kliničkog ispitivanja s jednodoznim GANFORT-om primijenjenim jedanput dnevno, najčešće prijavljena nuspojava s jednodoznim GANFORT-om bila je hiperemija konjunktive(uglavnom u tragovima ili u blagom obliku te se smatralo da nije upalne prirode) u približno 21% bolesnika, a koja je kod 1,4% bolesnika dovela do prekida terapije.